Olfr850, a member of the olfactory receptor family 7 subfamily G in Mus musculus (house mouse), plays a crucial role in the perception of odors. Olfactory receptors like Olfr850 belong to a vast family of G-protein-coupled receptors (GPCRs) characterized by a seven-transmembrane domain structure. These receptors are responsible for the recognition and transduction of odorant signals, initiating neuronal responses that lead to the perception of different smells. In the mouse genome, olfactory receptor genes are numerous and are uniquely named. Inhibition of Olfr850 can be achieved through various mechanisms, including the use of specific chemicals that target components of the olfactory signal transduction pathway. These inhibitors interfere with the downstream signaling events initiated by Olfr850 activation. For example, compounds like 2-Phenylphenol and Quinidine can directly or indirectly affect Olfr850 by disrupting GPCR-mediated signaling pathways, impairing the receptor's function. Similarly, Forskolin and H-89 can modulate adenylate cyclase and protein kinase A (PKA), respectively, key players in olfactory signal transduction, leading to Olfr850 inhibition. Additionally, compounds such as PD98059 and Rolipram influence the MAPK pathway and cAMP levels, indirectly affecting Olfr850 activation.
Pertussis Toxin, U73122, KN-93, Suramin, GDP-β-S, and Picrotoxin are other chemicals that can potentially inhibit Olfr850 through their actions on GPCRs, PLC, CaMKII, or neurotransmitter balance. These inhibitors collectively target various components of the olfactory signaling cascade, offering potential strategies for modulating Olfr850 activity and, consequently, the perception of odors. In conclusion, Olfr850 is a critical player in the olfaction process, and its inhibition can be achieved through the use of specific chemicals that interfere with olfactory signal transduction pathways. By targeting key components of these pathways, these inhibitors can disrupt the normal function of Olfr850, providing insights into potential strategies for modulating olfaction in mouse models.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
Quinidine is known to inhibit various G-protein-coupled receptors (GPCRs). It may directly affect Olfr850, impairing its function by interfering with GPCR-mediated signaling pathways involved in olfaction. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin indirectly influences Olfr850 by stimulating adenylate cyclase and increasing intracellular cAMP levels. Elevated cAMP can lead to desensitization of olfactory receptors, potentially inhibiting Olfr850. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a MEK inhibitor that affects the MAPK pathway. As olfactory receptors are involved in this pathway, PD98059 may indirectly inhibit Olfr850 by disrupting the signaling cascade and reducing receptor activation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram is a phosphodiesterase (PDE4) inhibitor that increases intracellular cAMP levels. Elevated cAMP can lead to desensitization of olfactory receptors, potentially inhibiting Olfr850 indirectly. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Pertussis toxin can inhibit G-protein-coupled receptors (GPCRs) by ADP-ribosylation of Gαi subunits. This disruption in GPCR signaling can potentially interfere with Olfr850 activation and olfactory perception. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 inhibits calcium/calmodulin-dependent protein kinase II (CaMKII), which is involved in olfactory signal transduction. By blocking CaMKII, KN-93 may disrupt the pathway and inhibit the activation of Olfr850. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
Suramin is a general GPCR antagonist. It can potentially inhibit Olfr850 by interfering with GPCR-mediated signal transduction. Suramin's non-specific binding to receptors may disrupt olfactory perception. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $66.00 $280.00 $1300.00 | 11 | |
Picrotoxin is a GABAA receptor antagonist. Although indirect, it can influence Olfr850 by modulating neuronal excitability and neurotransmitter balance in the olfactory system, potentially affecting olfaction. | ||||||